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Abstract 
A reverse phase high performance liquid chromatographic method has been described for the estimation of 
Eletriptan Hydrobromide in its pharmaceutical dosage forms using symmetry C18  (4.6×100nm, 3.5μm) column. 
In isocratic mode using phosphate buffer: Acetonitrile ratio of 60:40 v/v. The detection was carried out using 
UV detector at 221 nm. The linearity of Eletriptan Hydrobromide was found to be in the concentration range of 
10 to 50 μg/ ml. The flow rate was 0.9 ml/min and the run time was 6 min. The Eletriptan Hydrobromide 
retention time was observed to  be 2.29min .The developed method was  validated with respect to linearity, 
precision, accuracy and specificity as per the International Conference on Harmonisation (ICH) guidelines. The 
mean recoveries  were  found to be  within the limits. The developed method  was simple, fast, accurate and 
precise and has been successfully applied for the analysis of Eletriptan Hydrobromide in bulk sample and in 
pharmaceutical dosage forms. 
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I.  INTRODUCTION 
Eletriptan,  3-((R)-1-methyl-2-pyrrolidinyl) 
Methyl)-5-_2-(phenylsulfonyl)  ethyl-indole 
hydrobromide  (Fig.  1),  is a new  orally  active  5-HT 
1B/1D  agonist,  recently  approved  by  the  Food  and 
Drug  Administration  for  the  acute  treatment  of 
migraine headache. 
 
Figure 1 Eletriptan Hydrobromide 
 
Eletriptan  Hydrobromide  is  believed  to 
reduce swelling of the blood vessels surrounding the 
brain. This swelling is associated with the head pain of 
a migraine attack. Eletriptan Hydrobromide blocks the 
release  of  substance  from  nerve  endings  that  cause 
more  pain  and  other  symptoms  like  nausea,  and 
sensitivity to light and sound. It is thought that these 
actions contribute to relief of symptoms by Eletriptan 
Hydrobromide. A simple and accurate reverse phase 
liquid  chromatographic  and  UV-VIS  methods  are 
developed  for  the  determination  (1,  8)  of  Eletriptan 
hydrobromide. 
Pharmaceutical  analysis  includes  both 
qualitative  and  quantitative  analysis  of  drugs  and 
pharmaceutical  substances  starts  from  bulk  drugs  to 
the  finished  dosage  forms.  Most  frequently  used 
methods  for  quality  analysis  are  UV  spectroscopy, 
FTIR  and  liquid  chromatography  and  Mass 
spectroscopy  etc.  Among  them  High  performance 
liquid chromatography is basically a highly improved 
form of column chromatography. Instead of a solvent 
being allowed to drip through a column under gravity, 
it is forced through under high pressures of up to 400 
atmospheres (2,4). That makes it much faster. It also 
allows you to use a very much smaller particle size for 
the  column  packing  material  which  gives  a  much 
greater  surface  area  for  interactions  between  the 
stationary  phase  and  the  molecules  flowing  past  it. 
The chemical interaction of the stationary phase and 
the  sample  within  the  mobile  phase  determines  the 
degree of migration and separation of the components 
contained in the sample is the basic principle for High 
performance  liquid  chromatography  (HPCL)  (3,9). 
RP-HPLC  operates  on  the  principle  of  hydrophobic 
interactions, which originates from the high symmetry 
in  the  dipolar  water  structure  and  plays  the  most 
important  role  in  all  processes  in  life  science.  RP-
HPLC  allows  the  measurement  of  these  interactive 
forces.  The  binding  of  the  analyte  to  the  stationary 
phase  is  proportional  to  the  contact  surface  area 
around the non-polar segment of the analyte molecule 
upon  association  with  the  ligand  on  the  stationary 
phase. The validation criteria were given in Table -1. 
Table-1: Criteria for Validation of the Method 
CHARACTE
RISTICS 
ACCEPTA
BLE 
RANGE 
Accuracy  Recovery 
(98-102%) 
Precision,  RSD < 2% 
Intermediate 
precision  RSD < 2% 
Specificity  No 
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Interference 
LOD  S/N > 2 or 3 
LOQ  S/N > 10 
Linearity 
Correlation 
Coefficient(
r)>0.99 
Range  80-120% 
Stability  >24h or 
>12h 
 
However, the best of our knowledge there is 
no  available  analytical  method  for  Eletriptan 
hydrobromide, for its elution within a short duration. 
The aim of the present work is to develop a specific, 
precise,  accurate  and  rapid  method  to  elute  the 
Eletriptan hydrobromide in short span of time. 
 
II.  MATERIAL AND METHODS 
The  Chemicals/  Reagents,  Solvents  and 
instruments used are given in below table- 2 and 3 
Table-2: Shows Chemicals and Reagents 
S. No.  Chemicals/standards and reagents  Grade  Make 
1  Potassium dihydrogen phosphate  HPLC  Fisher 
2  Ortho phosphoric acid  HPLC  Fisher 
3  HPLC Grade Methanol  HPLC  Merck 
 
4  HPLC Grade Acetonitrile  HPLC  Merck 
 
5  Double Distilled Water  HPLC  Merck 
6  Eletriptan Hydrobromide  N/A   
 
Eletriptan  Hydrobromide  is  a  serotonin 
agonist,  specifically,  it  is  a  selective    5-
hydroxytryptamine 1B/1D(5-HT1B) receptor agonist. 
Eletriptan  Hydrobromide  binds  with high affinity  to 
the 5-HT1B,1D,1F receptors. It has a modest affinity 
to the 5-HT1A,1E,3B,7 receptors(12) 
 
Physical Properties:  
Mol.Mass    :       382.52 g/mol 
Melting Point            :       169-171°C 
PKa      :              Strongest 
acid -17.11 
                                           Strongest  base  -
8.37 
Water Solubility       :        Soluble 
 
Table- 3:  Shows Instruments and Equipments 
S.No
. 
Instruments 
and 
Equipments 
Softwar
e  Model  Company 
1  HPLC 
N 2000 
chromat
o 
graphic 
system 
Waters 
515pump
, 
Detector 
2487 
WATERS 
2 
UV-
Spectrophotome
ter 
UV 
Analyst 
UV- 
2310 
TECHCO
MP 
3  Weighing 
Balance  N/A  XEX 200  SHIMADZ
U 
4  Sonicator  N/A  SE60US  ENERTEC
H 
5  pH Meter  N/A  AD102U  ADWA 
 
 
III.  RESULTS AND DISCUSSION: 
UV  spectrum  was  recorded  for  Eletriptan 
Hydrobromide  individually  and  the  Lambda max  of 
Eletriptan  Hydrobromide  was  found  to  be  215  nm. 
UV-VIS spectrogram of Eletriptan Hydrobromide has 
shown  in  fig-  2.  It  was  found  that  Eletriptan 
Hydrobromide  can  effectively  be  analyzed  by  using 
the RP- HPLC method (4, 11). 
 
Fig 2: UV-VIS spectrum and accuracy assessment 
of Eletriptan hydrobromide 
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Table-4: Accuracy Observation of Eletriptan Hydrobromide  
% Concentration 
(at specification 
Level) 
Area 
Amount 
Added 
(mcg) 
Amount 
Found 
(mcg) 
% Recovery  Mean 
Recovery 
50 %  1982240  15.0  14.98  99.89 
101.96  100 %  2594119  30.0  30.59  101.96 
150 %  3269320  45.0  45.86  101.91 
 
The  accuracy  studies  were  shown  as  % 
recovery for Eletriptan Hydrobromide at 50 %, 100 % 
and 150 %( Table-4) the limits of % recovered should  
 
 
be in the range of 98-102 %. The results obtained for 
Eletriptan Hydrobromide were found to be within the 
limits.  Hence  the  method  was  found  to  be  accurate 
(fig-3)  
 
Fig 3: Precision and linearity of the Eletriptan at deferent dosages 
 
Table-5: Observation of System Precision 
INJECTION 
ELETRIPTAN 
HYDROBROMIDE  
AREA 
Injection1  2977138 
Injection2  2917756 
Injection3  2861139 
Injection4  2922541 
Injection5  2908272 
Average  2917369 
Standard 
Deviation  41363.63 
%  RSD  1.41784 
 
The  precision  of  an  analytical  procedure 
expresses the closeness of agreement among a series 
of measurements obtained from multiple samplings of  
 
the  same  homogenous  sample  under  prescribed 
conditions.  In  this  study  5  replicate  injections  of 
Eletriptan  Hydrobromide  formulation  (method 
precision) was performed %RSD was determined for 
peak areas (Table-5). The acceptance limit should be 
not more than 2 % and the results were obtained for 
standard samples (method precision) were found to be 
within the acceptance limits (6).  
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Table-6: Observation of Intermediate System 
Precision 
 
For Intermediate precision studies 5 replicate 
injections (Table-6) formulation (method id precision) 
was performed. % RSD was determined for peak areas 
of sample of ELETRIPTAN HYDROBROMIDE. The 
acceptance limit are should be not more than 2 % and 
the  results  were  obtained  for    sample  (method  ID 
precision)were  found  to  be  within  the  acceptance 
limits.  
The linearity of an analytical procedure is its 
ability  (within  a  given  range)  to  obtain  test  results, 
which are directly proportional to the concentration of 
the  analyte  in  the  sample  represented  in  fig-3  (10). 
The linearity range was found to be 10-50 µg/ml for 
Eletriptan  Hydrobromide.  Calibration  curve  was 
plotted  and  correlation  co-efficient  for  all  the  drugs 
are found to be 0.999. Hence the results obtained were 
within the acceptable limits. 
Table-7: Flow rate observation of Eletriptan 
Hydrobromide 
 
S.No 
 
Flow Rate 
(ml/min) 
System Suitability Results 
USP Plate 
Count  USP Tailing 
1  0.8  2516  1.3 
2     0.9  2549          
1.3 
3               1.0                 
2335 
                
1.3 
   
          *  Results  for  actual  flow  (ml/min)  have  been 
considered from Assay standard 
 
Table-8: Observation of System Suitability 
Parameters 
S. No  Parameter  ELETRIPTAN 
HYDROBROMIDE 
1  Retention time  2.3 
2  Theoretical plates  2549.0 
3  Tailing factor  1.3 
4  Area  3040909 
 
The system suitability Parameters were found 
to  be  within  the  specified  limits  (Table-8)  for  the 
proposed method. 
 
Table-9: Summarized RP-HPLC Method for 
Eletriptan Hydrobromide 
 
The limit of detection (LOD) represents the 
concentration of analyte. The limit of detection for the 
Eletriptan hydrobromide was found to be 0.19 μg ml
-1 
for  10  μl  (Table-9)  of  injection  volume.  The  LOQ 
represents  the  concentration  of  analyte  that  would 
yield a signal-to-noise ratio of 10 (fig-3). The limit of 
quantitation for the S-isomer was found to be 0.64 μg 
ml
-1 for the 10 μl of injection volume (5). 
The ruggedness of a method was defined as 
degree  of  reproducibility  of  results  obtained  by 
analysis of the same sample under a variety of normal 
test conditions such as different laboratories, different 
analysts, different instruments and different days(7). 
The robustness of an analytical procedure is 
measured  by  its  capability  to  remain  unaffected 
through  small,  but  deliberate,  variations  in  method 
parameters and provide an indication of its reliability 
during normal  usage.  In  the  varied  chromatographic 
conditions  like  flow  rate  was  found  to  be  >2.0 
illustrating the robustness of the method. The results 
are summarized on evaluation of the above results, it 
can  be  concluded  that  the  variation  in  flow  rate 
affected the method significantly (table-7). Hence it 
indicates that the method is robust even by change in 
the flow rate ±10 %. 
The  method  is  robust  only  in  less  flow 
condition. 
 
 
 
Injection 
ELETRIPTAN 
HYDROBROMIDE  
Area 
Injection1  3045134 
Injection2  3042317 
Injection3  3041284 
Injection4  3047977 
Injection5  3056220 
Mean  3046586.4 
Standard Deviation  5983.15772 
% RSD  0.196388907 
S.No  Parameter  Acceptance 
criteria  Results 
1  System 
suitability 
Theoretical 
Plates-
NLT2000 
2549 
Tailing factor-
NMT 2  1.3 
Resolution- 
NLT 2  0.0 
2  Precision  % RSD  1.41 
3  ID  
Precision 
% RSD 
  0.19 
4  Linearity 
Correlation 
coefficient 
NLT 0.999 
0.9990 
5  Accuracy 
Percentage 
Recovery 
98-102% 
101.96 
6  LOD  0.19ug/ml 
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IV.  CONCLUSION 
  The  evaluation  of  obtained  values  suggests  that 
the  proposed  HPLC  methods  provide  simple, 
precise,  rapid  and  robust  quantitative  analytical 
method  for  estimation  of  Eletriptan 
HydroBromide in pharmaceutical dosage form.  
  The  mobile  phase  is  simple  to  prepare  and 
economical.  
  As I validated method as per ICH guidelines and 
correlating  obtained  values  with  the  standard 
values, satisfactory results were obtained.   
  Hence, the method can be easily and conveniently 
adopted  for  routine  estimation  of  Eletriptan 
HydroBromide in pharmaceutical dosage form.   
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